PMA device
Boston Orthokeratology (oprifocon A) Shaping lens for Overnight Wear for Bausch + Lomb Vision Shaping Treatment
Bausch & Lomb · Lens, Contact, Orthokeratology, Overnight (NUU, Class III) · First FDA decision Feb 21, 2006, newest Feb 20, 2025Nearsightedness and refractive error
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
349
Naming "Boston"
MAUDE reports
591
Brand "Boston", since 2015
PubMed studies
21,110
Mentioning "Boston"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Boston Orthokeratology (oprifocon A) Shaping lens for Overnight Wear for Bausch + Lomb Vision Shaping Treatment
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- Boston Orthokeratology (oprifocon A) Shaping lens for Overnight Wear for Bausch + Lomb Vision Shaping TreatmentPMA supplement
P010062-S014 · Decided Feb 20, 2025 · 90 days after receipt · Normal 180 Day Track
Device type: Lens, contact, orthokeratology, overnight (NUU) · Ophthalmology
- BOSTON ORTHOKERATOLOGY (OPRIFOCON A) SHAPING LENSPMA supplement
P010062-S008 · Decided Jul 28, 2014 · 1,377 days after receipt · Normal 180 Day Track No User Fee
Device type: Lens, contact, orthokeratology, overnight (NUU) · Ophthalmology
P010062-S003 · Decided Feb 21, 2006 · 309 days after receipt · Normal 180 Day Track No User Fee
Device type: Lens, contact, orthokeratology, overnight (NUU) · Ophthalmology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Boston", any status and sponsor, newest update first.
Boston Scientific CorporationPublic (BSX)
NCT04674969 · 5,000 participants (planned) · Start Mar 29, 2021 · Primary completion Jan 2028
Device: Any eligible commercially available Boston Scientific Corporation (BSC) drug-eluting device. · For: Peripheral Vascular Diseases
Sites: Jonesboro, Arkansas; Los Angeles, California; Sacramento, California · 89 sites in all
- Pulsed Field Ablation of Atrial Fibrillation: CENTAURI Versus FARAPULSEPivotal-lookingCompleted
St. Anne's University Hospital Brno, Czech RepublicAcademic, hospital or other
NCT07902739 · 325 participants · Start May 17, 2024 · Primary completion Oct 5, 2026
Device: CENTAURI PEF system; FARAPULSE system · For: Atrial Fibrillation (AF); Paroxysmal AF; Persistent AF
Sites: Brno, Czechia
- Vercise™ DBS Dystonia Prospective StudyRecruiting
Boston Scientific CorporationPublic (BSX)
NCT02686125 · 300 participants (planned) · Start Mar 7, 2016 · Primary completion Dec 2030
Device: Deep Brain Stimulation (DBS) · For: Dystonia
Sites: Ghent, Belgium; Leuven, Belgium; Halifax, Canada · 36 sites in all
346 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Boston", and for the whole product code for context.
This brand
591 reports: 215 malfunction, 330 injury, 15 death
Whole product code NUU
40 reports: 3 malfunction, 37 injury, 0 death
Newest reports for this brand
MW6004389 · Received Oct 21, 2026 · Event dated Oct 13, 2026
Device type: Catheter, Ultrasound, Intravascular (OBJ)
Device problem as coded: Erratic or Intermittent Display; Defective Device
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
MW6004283 · Received Oct 20, 2026 · Event dated Oct 7, 2026
Device type: Catheter, Ultrasound, Intravascular (OBJ)
Device problem as coded: Poor Quality Image; Optical Discoloration
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
MW6004096 · Received Oct 16, 2026 · Event dated Oct 10, 2026
Device type: Detector And Alarm, Arrhythmia (DSI)
Device problem as coded: Loss of or Failure to Bond; Gel Leak; Patient-Device Incompatibility; Output below Specifications
Patient problem as coded: Erythema; Skin Inflammation/ Irritation
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Boston"[tiab]. The summary above synthesizes these.
- The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study.
Charidimou A, Boulouis G, Frosch MP, et al. · Lancet Neurol · 2022Multicenter Study, Research Support, Non-U.S. Gov't
- Boston, USA.
Xiang DH · Lancet Psychiatry · 2022
- Behavioral epigenetics.
Lester BM, Tronick E, Nestler E, et al. · Ann N Y Acad Sci · 2011Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- Lessons from Boston.
Kellermann AL, Peleg K · N Engl J Med · 2013
- BOSTON'S DEATH RATE.
Davis WH · Am J Public Health (N Y) · 1912
- [The Boston keratoprosthesis].
Wang L, Huang Y, James C, et al. · Zhonghua Yan Ke Za Zhi · 2014English Abstract
- Notice.
Horm Behav · 1996
- Boston Letter.
Hub · Int Dent J (Phila) · 1902
- Boston Letter.
Chic Med J Exam · 1882
- Boston Letter.
Chic Med J Exam · 1881
- Boston Milk.
Buffalo Med Surg J · 1871
- Boston, 1953.
Meyerhoff HA · Science · 1953
Other devices of this type
Also filed under product code NUU.
- Euclid Orthokeratology (oprifocon A) Contact Lenses for Overnight Wear and Euclid Orthokeratology (tisilfocon A) ContactEuclid Vision Corporation · PMA 2026
- Menicon Z Night (tisilfocon A) Contact Lenses for Overnight WearMenicon Co, Ltd. · PMA 2022
- Paragon Z CRT (tisilfocon A) and Paragon Z CRT Dual Axis (tisilfocon A) Rigid Gas Permeable Contact lenses in blue tintCooperVision, Inc. · PMA 2019
- Jsz Orthokeratology (Oprifocon A) Contact Lenses for Overnight WearEuclid Vision Corporation · PMA 2016
- DilightTM (roflufocon E) Overnight Orthokeratology Contact LensTianjin MasterVision Technology Co., Ltd. · PMA 2026
- Optimum Infinite (tisilfocon A) Orthokeratology Lenses IIContamac, Ltd. · PMA 2026
- ACUVUE® Abiliti Overnight and ACUVUE® Abiliti Overnight Therapeutic Lenses for Myopia ManagementMenicon Co, Ltd. · PMA 2021
- Orthokeratology (tisilfocon A) Contact Lenses for Overnight WearEuclid Vision Corporation · PMA 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.